SOUTH SAN FRANCISCO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (œTitan or the œCompany) today announced that by letter dated January 24, 2024, the...
SOUTH SAN FRANCISCO, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (Titan or the Company) today announced that its Board of Directors has approved a...
Titan Pharmaceuticals Provides Shareholder Update